Masayasu Kitano Selected Research

Masayasu Kitano Research Topics

Disease

6	Rheumatoid Arthritis 01/2017 - 06/2003
4	Inflammation (Inflammations) 01/2020 - 03/2006
4	Fever (Fevers) 01/2017 - 05/2003
4	Multiple Myeloma 01/2005 - 01/2002
3	Arthritis (Polyarthritis) 01/2015 - 05/2003
2	Vasculitis (Vasculitides) 12/2022 - 01/2010
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019 - 06/2003
2	Amyopathic dermatomyositis 09/2019 - 01/2016
2	Melanoma (Melanoma, Malignant) 09/2019 - 01/2016
2	Dermatomyositis (Dermatopolymyositis) 09/2019 - 01/2016
2	Polymyositis 01/2017 - 01/2016
2	Systemic Scleroderma (Systemic Sclerosis) 01/2011 - 06/2003
2	Neoplasms (Cancer) 02/2008 - 03/2006
2	Bone Diseases (Bone Disease) 01/2005 - 01/2002
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2022
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2020
1	Ulcer 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	ST Elevation Myocardial Infarction 01/2020
1	Pain (Aches) 02/2018
1	Hypersensitivity (Allergy) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Hemolytic Anemia 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2016
1	Xerostomia 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2016
1	Abdominal Pain (Pain, Abdominal) 01/2016
1	Diarrhea 01/2015
1	Ankylosing Spondylitis 01/2015
1	Hemolysis 01/2015
1	HELLP Syndrome 01/2015
1	Amyloidosis 01/2015
1	Melena 01/2015
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2011
1	Bacterial Infections (Bacterial Infection) 01/2011
1	Tuberculosis (Tuberculoses) 01/2011
1	Tuberculous Peritonitis 01/2011
1	Ascites 01/2011
1	Otitis Media 01/2010
1	Experimental Arthritis 01/2009
1	Pure Autonomic Failure 01/2006
1	Autoimmune Diseases (Autoimmune Disease) 01/2004
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2004
1	Large Granular Lymphocytic Leukemia 01/2004
1	Bone Resorption 10/2003
1	Cryoglobulinemia 06/2003

Drug/Important Bio-Agent (IBA)

4	C-Reactive ProteinIBA 01/2020 - 05/2003
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 10/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 01/2010
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 03/2012 - 03/2006
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2003 - 03/2002
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2022 - 01/2010
2	Ferritins (Ferritin)IBA 09/2019 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 05/2019 - 05/2016
2	CollagenIBA 01/2018 - 01/2005
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 01/2015
2	Colchicine FDA LinkGeneric 01/2017 - 01/2016
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2016 - 01/2016
2	Diphosphonates (Bisphosphonates)IBA 01/2005 - 01/2002
2	Interleukin-18 (Interleukin 18)IBA 01/2004 - 05/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2003 - 03/2002
1	Rituximab (Mabthera)FDA Link 12/2022
1	B-Cell Activating FactorIBA 12/2022
1	Infliximab (Remicade)FDA Link 01/2020
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2019
1	InterleukinsIBA 09/2019
1	NeopterinIBA 09/2019
1	Anti-Citrullinated Protein AntibodiesIBA 02/2018
1	Rheumatoid FactorIBA 02/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2017
1	AutoantibodiesIBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Adalimumab (Humira)FDA Link 01/2015
1	EnzymesIBA 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2012
1	LigandsIBA 03/2012
1	Etanercept (Enbrel)FDA Link 01/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2011
1	Metronidazole (Metric)FDA LinkGeneric 01/2011
1	Adenosine DeaminaseIBA 01/2011
1	Tumor Necrosis Factor InhibitorsIBA 01/2011
1	Phosphotransferases (Kinase)IBA 01/2009
1	Imatinib Mesylate (Gleevec)FDA Link 01/2009
1	cevimeline (Evoxac)FDA Link 01/2006
1	Cholinergic Agents (Cholinergics)IBA 01/2006
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2005
1	CalciumIBA 01/2005
1	OsteopontinIBA 10/2003
1	ThrombomodulinIBA 06/2003

Therapy/Procedure

4	Therapeutics 09/2019 - 01/2005
2	Remission Induction 12/2022 - 09/2019
2	Drug Therapy (Chemotherapy) 03/2002 - 01/2002
1	Thrombectomy 01/2020
1	Plasma Exchange 01/2017
1	Oral Administration 01/2009